Suppr超能文献

紫杉醇的临床应用、抗癌机制、全化学合成、半合成及生物合成的研究进展。

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel.

机构信息

Key Laboratory of Molecular Pharmacology and Drug Evaluation (Ministry of Education), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, School of Pharmacy, Yantai University, Yantai 264005, China.

School of Pharmacy, Binzhou Medical University, Yantai 264003, China.

出版信息

Molecules. 2023 Nov 10;28(22):7517. doi: 10.3390/molecules28227517.

Abstract

Paclitaxel, a natural secondary metabolite isolated and purified from the bark of the tree, is considered one of the most successful natural anticancer drugs due to its low toxicity, high potency and broad-spectrum anticancer activity. trees are scarce and slow-growing, and with extremely low paclitaxel content, the contradiction between supply and demand in the market is becoming more and more intense. Therefore, researchers have tried to obtain paclitaxel by various methods such as chemical synthesis, artificial culture, microbial fermentation and tissue cell culture to meet the clinical demand for this drug. This paper provides a comprehensive overview of paclitaxel extraction, combination therapy, total synthesis, semi-synthesis and biosynthesis in recent years and provides an outlook, aiming to provide a theoretical basis and reference for further research on the production and application of paclitaxel in the future.

摘要

紫杉醇是从树皮中分离和纯化的天然次生代谢物,因其低毒性、高效性和广谱抗癌活性而被认为是最成功的天然抗癌药物之一。但由于 树资源稀缺,生长缓慢,紫杉醇含量极低,市场供需矛盾日益加剧。因此,研究人员试图通过化学合成、人工培养、微生物发酵和组织细胞培养等各种方法获得紫杉醇,以满足临床对该药物的需求。本文综述了近年来紫杉醇的提取、联合治疗、全合成、半合成和生物合成的研究进展,并对其进行了展望,旨在为紫杉醇未来的生产和应用研究提供理论依据和参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39fe/10673093/9cd85316f446/molecules-28-07517-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验